Medley Pharmaceuticals
Medley Pharmaceuticals Ltd. is dedicated to developing and providing a wide range of pharmaceutical products, including the Prokinetic drug Gutfast, which is used for functional gastrointestinal disorders such as IBS, GERD, and reflux esophagitis. The company's mission is to offer effective medications with minimal adverse effects, supporting gastrointestinal health and overall well-being.
Industries
health-care
manufacturing
pharmaceutical
Nr. of Employees
Very Large (1000+)
Products
Gutfast
Oral fixed-dose combination tablet containing a proton‑pump inhibitor and a prokinetic agent, indicated for functional dyspepsia, gastroesophageal reflux disease, irritable bowel syndrome with constipation, and reflux esophagitis. Administered once daily.
Gutfast
Oral fixed-dose combination tablet containing a proton‑pump inhibitor and a prokinetic agent, indicated for functional dyspepsia, gastroesophageal reflux disease, irritable bowel syndrome with constipation, and reflux esophagitis. Administered once daily.
Expertise Areas
- Gastrointestinal therapeutics
- Oral formulation development
- Fixed-dose combination products
- Sustained-release formulation
Key Technologies
- Sustained-release oral formulation
- Fixed-dose combination tablet formulation
- Oral tablet dosage form
- API dose-strength specification